NL7803247A - Preparaat ter bestrijding van ontsteking. - Google Patents

Preparaat ter bestrijding van ontsteking.

Info

Publication number
NL7803247A
NL7803247A NL7803247A NL7803247A NL7803247A NL 7803247 A NL7803247 A NL 7803247A NL 7803247 A NL7803247 A NL 7803247A NL 7803247 A NL7803247 A NL 7803247A NL 7803247 A NL7803247 A NL 7803247A
Authority
NL
Netherlands
Prior art keywords
against inflammation
preparation against
preparation
inflammation
cl2mdp
Prior art date
Application number
NL7803247A
Other languages
English (en)
Other versions
NL175882B (nl
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NL7803247A publication Critical patent/NL7803247A/nl
Publication of NL175882B publication Critical patent/NL175882B/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
NLAANVRAGE7803247,A 1977-03-28 1978-03-28 Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat. NL175882B (nl)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US78214377A 1977-03-28 1977-03-28
US78214477A 1977-03-28 1977-03-28
US80189577A 1977-05-31 1977-05-31
US80189677A 1977-05-31 1977-05-31
US80170577A 1977-05-31 1977-05-31
US80170477A 1977-05-31 1977-05-31
US80170777A 1977-05-31 1977-05-31
SE7806449A SE441493B (sv) 1977-03-28 1978-06-01 Antiinflammatorisk komposition innefattande en salicylsyrabaserad, antiinflammatorisk forening och ett organofosfonat
CH601678A CH645542A5 (de) 1977-03-28 1978-06-01 Entzuendungshemmende arzneimittelpraeparate.
SE8001363A SE441494B (sv) 1977-03-28 1980-02-21 Antiinflammatorisk komposition innefattande en indolbaserad, antiinflammatorisk forening och ett organofosfonat

Publications (2)

Publication Number Publication Date
NL7803247A true NL7803247A (nl) 1978-10-02
NL175882B NL175882B (nl) 1984-08-16

Family

ID=27579075

Family Applications (2)

Application Number Title Priority Date Filing Date
NLAANVRAGE7803247,A NL175882C (nl) 1977-03-28 Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.
NLAANVRAGE7803247,A NL175882B (nl) 1977-03-28 1978-03-28 Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7803247,A NL175882C (nl) 1977-03-28 Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.

Country Status (11)

Country Link
US (1) US4269828A (nl)
JP (1) JPS542340A (nl)
AU (1) AU524180B2 (nl)
BE (1) BE865370A (nl)
CA (1) CA1109794A (nl)
CH (1) CH645542A5 (nl)
DE (1) DE2813165C2 (nl)
FR (1) FR2385398A1 (nl)
GB (1) GB1588284A (nl)
NL (2) NL175882B (nl)
SE (2) SE441493B (nl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602040A (en) * 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
CA1229554A (en) * 1983-04-18 1987-11-24 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
DE3324193A1 (de) * 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
JPH0639449B2 (ja) * 1989-04-10 1994-05-25 エーザイ株式会社 ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬
EP0550385A1 (de) * 1991-12-19 1993-07-07 Ciba-Geigy Ag Peroral zu verabreichende pharmazeutische Zusammensetzungen, die Methandiphosphonsäure-Derivate und 18-Krone-6 Ether enthalten
DK0650361T3 (da) * 1992-06-30 1999-06-23 Procter & Gamble Pharma Sammensætninger til behandling af arthritis, hvilke sammensætninger indeholder phosphonater og NSAID'er
SE9303740L (sv) * 1993-11-12 1995-05-13 Leiras Oy Farmaceutisk komposition
US5652227A (en) * 1995-01-30 1997-07-29 Teronen; Olli Pekka Inhibition of the degradation of connective tissue matrix protein components in mammals
WO1997013519A1 (en) * 1995-10-09 1997-04-17 Russinsky Limited Esters of cyclooxygenase inhibitors and terpene derivatives as pharmaceutical products
DE19615577A1 (de) * 1996-04-19 1997-10-23 Beiersdorf Ag Verwendung von Salicin als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
SE9703691D0 (sv) * 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
DE10049735A1 (de) * 2000-09-28 2002-04-18 Jenapharm Gmbh Verfahren zur Isolierung von pharmazeutisch verwertbarem Etidronat-Dinatrium
AUPR283801A0 (en) * 2001-02-01 2001-03-01 Australian National University, The Chemical compounds and methods
CN103932988A (zh) * 2009-04-24 2014-07-23 伊休蒂卡有限公司 吲哚美辛的新剂型

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3584125A (en) * 1968-12-23 1971-06-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3553314A (en) * 1968-12-23 1971-01-05 Procter & Gamble Oral compositions for calculus retardation
US3553315A (en) * 1968-12-24 1971-01-05 Procter & Gamble Oral compositions for calculus retardation
US3584124A (en) * 1968-12-24 1971-06-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3678164A (en) * 1969-02-12 1972-07-18 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3641246A (en) * 1970-01-14 1972-02-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phcosphate in animal tissue
US3662066A (en) * 1970-03-04 1972-05-09 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US4044125A (en) * 1975-07-18 1977-08-23 Eli Lilly And Company Method of stabilizing acetylsalicylic acid in the presence of d-propoxyphene hydrochloride and compositions thereof
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin

Also Published As

Publication number Publication date
BE865370A (fr) 1978-09-28
US4269828A (en) 1981-05-26
AU524180B2 (en) 1982-09-02
CH645542A5 (de) 1984-10-15
CA1109794A (en) 1981-09-29
GB1588284A (en) 1981-04-23
NL175882B (nl) 1984-08-16
AU3451178A (en) 1979-10-04
SE7806449L (sv) 1979-12-02
DE2813165C2 (de) 1983-12-15
SE441494B (sv) 1985-10-14
DE2813165A1 (de) 1978-10-12
FR2385398B1 (nl) 1980-04-04
SE8001363L (sv) 1980-02-21
SE441493B (sv) 1985-10-14
FR2385398A1 (fr) 1978-10-27
JPS542340A (en) 1979-01-09
NL175882C (nl)

Similar Documents

Publication Publication Date Title
IT7823672A0 (it) Derivati di idantoina ad azione terapeutica e relativo procedimento di preparazione.
NL7803247A (nl) Preparaat ter bestrijding van ontsteking.
FR2344287A1 (fr) Compositions pharmaceutiques anti-inflammatoires
ES2071986T3 (es) Enmascaramiento del sabor del ibuprofeno con revestimiento en lecho fluidificado.
IT8025206A0 (it) Derivati di 4-fenil-ftalazine ad azione terapeutica.
NL190702B (nl) 4h-pyrido(1,2-a)pyrimidin-4-on verbinding met anti-allergische werkzaamheid, alsmede farmaceutisch preparaat daarvan.
SE384856B (sv) Sett att framstella indolderivat med anti-inflammatorisk, analgetisk och antipyretisk verkan
AT346474B (de) Kranken- bzw. nachtstuhl
IT1143009B (it) Composti farmaceutici ad azione antisecretiva e procedimento di preparazione
CA971013A (en) Disposable surgical lighting pipe
NO149428C (no) Fremgangsmaate for fremstilling av fysiologisk aktive prostaglandinderivater.
SE396387B (sv) Forfarande for framstellning av 1-(2-karboxikromonyloxi)-2-hydroxi-3-p-cyanfenoxi-propaner med terapentisk verkan
SE403911B (sv) Forfarande for framstellning av aroylsubstituerade fenylettiksyraderivat med anti-inflammatorisk verkan
NL172157C (nl) Preparaat met bloeddrukverlagende werking en de daarvoor geschikte werkzame verbindingen.
IT1106299B (it) 5-imminodaunomicina e suoi derivati procedimento per prepararla nonch' composizioni farmaceutiche che la contengono
NL192111B (nl) Geneesmiddelpreparaat met anti-inflammatoire werking.
IT8721687A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropiridin-3-carbossa ldeide, loro procedimento di preparazione e loro impiego come sostanze medicinali.
NO147483C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner.
NO891574L (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
SE380533B (sv) Forfarande for framstellning av 17-hydroxi-7-(alkoxi-eller alkyltio-) karbonyl-3-oxo-17alfa-pregn-4-en-21-karbonsyra-gamma-laktoner
SE385906B (sv) Forfarande for framstellning av kardenolid-3-(2'-desoxi-glykosider)
SE7708824L (sv) Forfarande for framstellning av 2,6-di-tert butylfenol
SE388195B (sv) Forfarande for framstellning av 2,5-dihydroxibensensulfonsyraderivat med hemostatisk hypokolesterolemisk, hypotriglyceridemisk och hypolipemisk verkan
NL7809562A (nl) Farmaceutisch preparaat met anti-inflammatoire werking en werkwijze ter bereiding van het preparaat.
IT1162605B (it) Composti della serie beta-lattamica procedimento per produrli e preparato farmaceutico che li comprende

Legal Events

Date Code Title Description
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee